Medicine Safety
When it comes to medicines, safety has many meanings and many stakeholders: Volunteers in clinical trials, researchers and technicians working in laboratories and manufacturing facilities, regulators at the Food and Drug Administration (FDA), physicians prescribing medicines, and patients who rely on those therapies to lead healthier, longer lives—all have vested interests in drug safety. The safety and integrity of medicines is critical to America’s biopharmaceutical industry and the patients we serve. Learn more about the key medical safety issues facing our industry today.
For a Healthier U.S.: Methods to Fight Prescription Abuse
80% of counterfeit drugs are produced overseas
Latest From The Blog
blog url
How the Vaccines for Children program protects America's kids
October 14, 2026
Recognizing the transformative impact of intellectual property
October 13, 2026
Employers faced $12.8 billion in higher costs due to 340B in 2025
October 5, 2026
PhRMA Foundation makes unprecedented investment in America’s future scientific workforce
October 5, 2026
New Report: Hospitals, clinics and for-profit partners pocketed $142B in 2025 from 340B
October 1, 2026
Patients are paying more for their premiums and getting less
September 30, 2026
Hospitals are hiding information that could lower costs for patients
September 24, 2026
ICYMI: Pennsylvania shows what biopharmaceutical innovation can deliver
September 21, 2026
New poll: 2 in 3 voters prefer a candidate committed to lowering health insurance premiums
September 18, 2026